Mathias Schmidt: Email & Phone Number

Work Experience 35 years

President and CEO of ArmaGen, Executive Fellow and Executive Advisor JCR Pharmaceuticals Co Ltd at ArmaGen, Inc and JCR Pharmaceuticals

Jun 2024 - Current

President and CEO of JCR USA & ArmaGen, Senior Executive Director global Strategy, Board Member at JCR Pharmaceuticals Co Ltd

Jun 2020 - Jun 2024

Vice President Clinical Development, Business Development, global business expansion at JCR Pharmaceuticals Co Ltd

Apr 2020 - Jun 2024

President and CEO, ArmaGen, Inc. at ArmaGen, Inc.

Oct 2016 - May 2024

Consulting President and CEO at ArmaGen, Inc.

Mar 2019 - Jun 2020

Chief Executive Officer at ArmaGen, Inc.

Oct 2016 - Mar 2019

Executive Vice President at Triphase Accelerator Corporation

Mar 2019 - Jun 2020

Board Member at Susan G. Komen San Diego

Nov 2015 - Nov 2017

Vice President Biological Sciences at Takeda

Jun 2012 - Sep 2016

Principal & Head of Biologics Department at Takeda Pharmaceuticals (formerly Nycomed)

Oct 2010 - May 2012

Founder at Cycle Screen Technologies

Mar 2008 - Mar 2011

Senior Manager and Associate Principal, Strategic Planning and Business Support at Takeda Pharmaceuticals (formerly Nycomed)

Jun 2007 - Dec 2009

Laboratory Head and Senior Group Leader, Oncology at Altana Pharma

Apr 2001 - May 2007

Head of Laboratory at ASTA Medica GmbH

Oct 1999 - Mar 2001

Researcher at UT MD Anderson

Jan 1998 - Sep 1999

Guest Scientist at Ciba-Geigy

Feb 1996 - Dec 1996

Intern at Boehringer Mannheim

Jul 1991 - Oct 1991

Mathias is proficient in English and German. Their professional focus is Alliance Management, Biologics, and Biopharmaceuticals across 3 core areas.

Mathias holds • Certified to operate with biohazardous material risk class 2 according to §44 German InfSGes. certifications and has been awarded Elected Board Member Biolago Biotech cluster region, Germany, Venia Legendi in Molecular Pharmacology and Cell Biology, and Innovation Award